WeVote
Log In

Bill

Bill

AB 1152

Controlled substances: human chorionic gonadotropin.

2025-2026 Regular Session Introduced by Joe Patterson

California law reclassifies human chorionic gonadotropin (hCG) as a controlled substance, potentially restricting access to fertility treatments and weight-loss applications.

Chaptered by Secretary of State - Chapter 183, Statutes of 2025.
#controlledsubstances #humanchorionicgonadotropin
0
WeVote Research Nonpartisan
Bill Summary · AB 1152

Legislative bill overview

AB 1152 regulates human chorionic gonadotropin (hCG), a hormone used in fertility treatments and weight-loss protocols, by classifying it as a controlled substance under California law. The bill was signed into law in October 2025 after passing through both chambers of the legislature with modifications.

Why is this important

This legislation affects access to fertility treatments and off-label weight-loss medications that rely on hCG. The reclassification could impact prescribing practices, patient access, and medical providers' ability to offer these treatments, with implications for reproductive healthcare and medical autonomy in California.

Potential points of contention

  • Fertility treatment access: Restricting hCG as a controlled substance may complicate legitimate fertility protocols and create barriers for patients seeking reproductive assistance
  • Weight-loss medication debates: hCG is promoted in some circles for weight management despite limited FDA support; classification reflects disagreement over its efficacy and appropriate use
  • Medical autonomy vs. regulation: The bill represents tension between preventing misuse of hormonal substances and preserving physician discretion in prescribing practices

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.